• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SMA1 和 SMA2 患儿的运动功能取决于颈部和躯干肌肉力量、脊柱变形以及肢体关节活动范围。

Motor Function of Children with SMA1 and SMA2 Depends on the Neck and Trunk Muscle Strength, Deformation of the Spine, and the Range of Motion in the Limb Joints.

机构信息

Department of Rehabilitation, Józef Piłsudski University of Physical Education, Marymoncka Str., 00-968 Warszawa, Poland.

Department of Developmental Neurology, Poznan University of Medical Sciences, 49 Przybyszewskiego Str, 60-355 Poznan, Poland.

出版信息

Int J Environ Res Public Health. 2021 Aug 30;18(17):9134. doi: 10.3390/ijerph18179134.

DOI:10.3390/ijerph18179134
PMID:34501722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8430973/
Abstract

The purpose of this study was to investigate the functional relationships between selected ranges of motion of the neck, upper and lower limbs, the strength of the neck and trunk muscles, postural parameters, and the motor function of children with SMA1 and SMA2-27 children, aged 6 months-15 years, with genetically confirmed spinal muscular atrophy type 1 (19 children) and 2 (8 children) undergoing pharmacological treatment. All children were examined, according to the methodology, including the motor function evaluation, measurement of selected ranges of motion, assessment of postural parameters, and measurement of neck and trunk muscle strength. The functional status of 15 children was assessed with the CHOP INTEND (CHOP group) scale and of 12 children with the HFMSE (HFMSE group). The results obtained showed that, in children examined with the CHOP scale, greater limitation of flexion in the shoulder joints was observed. As the deformation of the chest increased, the functional abilities of children deteriorated. In participants examined with the CHOP group, the ranges of neck rotation decreased with the increase of the chest deformity. In the HFMSE group, the ranges of head rotation showed a strong relationship with some parameters of muscle strength and the sum of the R coefficients. Participants showed many significant relationships between the range of motion in the neck and joints of the limbs, with more significant relationships in the CHOP group. The following conclusions were made: motor skills of children with SMA depend on muscle strength, range of motion, and deformities of the spine and chest; the development of scoliosis adversely affects the motor function, ranges of motion, and muscle strength; and movement ranges are related to motor skills and strength values.

摘要

本研究旨在探讨颈部、上下肢的特定活动范围、颈部和躯干肌肉力量、姿势参数与脊髓性肌萎缩症 1 型(SMA1)和 2 型-27 型(SMA2-27)儿童运动功能之间的功能关系。对接受基因确认的脊髓性肌萎缩症 1 型(19 名儿童)和 2 型(8 名儿童)治疗的 6 个月至 15 岁儿童进行了药物治疗。所有儿童均按运动功能评估、特定活动范围测量、姿势参数评估和颈部及躯干肌肉力量测量的方法进行检查。15 名儿童的功能状态采用 CHOP INTEND(CHOP 组)量表进行评估,12 名儿童采用 HFMSE(HFMSE 组)量表进行评估。研究结果表明,在接受 CHOP 量表评估的儿童中,肩关节屈伸受限程度较大。随着胸廓变形程度的增加,儿童的功能能力恶化。在接受 CHOP 组检查的参与者中,颈部旋转范围随胸廓畸形程度的增加而减小。在 HFMSE 组中,头部旋转范围与肌肉力量和 R 系数之和的某些参数具有很强的相关性。参与者在颈部运动范围与四肢关节之间表现出许多显著的关系,而在 CHOP 组中这些关系更为显著。得出以下结论:SMA 儿童的运动技能取决于肌肉力量、活动范围和脊柱及胸廓的畸形;脊柱侧凸的发展对运动功能、活动范围和肌肉力量有不利影响;运动范围与运动技能和力量值有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/28819e3ff853/ijerph-18-09134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/96ea2d94ada4/ijerph-18-09134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/bdfdd11b83d5/ijerph-18-09134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/bfc0f0d2ee3a/ijerph-18-09134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/28819e3ff853/ijerph-18-09134-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/96ea2d94ada4/ijerph-18-09134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/bdfdd11b83d5/ijerph-18-09134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/bfc0f0d2ee3a/ijerph-18-09134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e2/8430973/28819e3ff853/ijerph-18-09134-g004.jpg

相似文献

1
Motor Function of Children with SMA1 and SMA2 Depends on the Neck and Trunk Muscle Strength, Deformation of the Spine, and the Range of Motion in the Limb Joints.SMA1 和 SMA2 患儿的运动功能取决于颈部和躯干肌肉力量、脊柱变形以及肢体关节活动范围。
Int J Environ Res Public Health. 2021 Aug 30;18(17):9134. doi: 10.3390/ijerph18179134.
2
Neck and Trunk Muscle Strength in Children With Spinal Muscular Atrophy Is Lower Than in Healthy Controls and Depends on Disease Type.脊髓性肌萎缩症患儿的颈部和躯干肌肉力量低于健康对照儿童,且取决于疾病类型。
Front Neurol. 2021 Apr 30;12:628414. doi: 10.3389/fneur.2021.628414. eCollection 2021.
3
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta-analysis.利司扑兰治疗脊髓性肌萎缩症的疗效:系统评价和荟萃分析。
Pharmacotherapy. 2024 Jan;44(1):97-105. doi: 10.1002/phar.2866. Epub 2023 Aug 21.
4
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.180 例脊髓性肌萎缩症 1c-4 型患者的横断面队列研究中贯穿一生的肌肉力量和运动功能。
Eur J Neurol. 2018 Mar;25(3):512-518. doi: 10.1111/ene.13534. Epub 2018 Feb 2.
5
Drug treatment for spinal muscular atrophy types II and III.脊髓性肌萎缩症II型和III型的药物治疗。
Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5.
6
Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1.脊柱肌萎缩症患者中,高功能个体的脊柱侧弯手术显著影响运动能力。
J Neuromuscul Dis. 2020;7(2):183-192. doi: 10.3233/JND-190462.
7
Muscle strength and motor function in adolescents and adults with spinal muscular atrophy.青少年和成年脊髓性肌萎缩症患者的肌肉力量和运动功能。
Neurology. 2020 Oct 6;95(14):e1988-e1998. doi: 10.1212/WNL.0000000000010540. Epub 2020 Jul 30.
8
Reliability of four tests to assess body posture and the range of selected movements in individuals with spinal muscular atrophy.四种测试评估脊髓性肌萎缩症患者身体姿势及特定运动范围的可靠性。
BMC Musculoskelet Disord. 2019 Feb 7;20(1):54. doi: 10.1186/s12891-018-2389-8.
9
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III.扩大版哈默史密斯功能运动量表在II型和III型脊髓性肌萎缩症中的效度验证。
J Child Neurol. 2011 Dec;26(12):1499-507. doi: 10.1177/0883073811420294. Epub 2011 Sep 21.
10
Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy.脊髓性肌萎缩症患者上肢功能检查及其与粗大运动功能和结构参数的关系
Biomedicines. 2023 Mar 24;11(4):1005. doi: 10.3390/biomedicines11041005.

引用本文的文献

1
Functional and structural analysis of SITTER patients with spinal muscular atrophy.脊髓性肌萎缩症SITTER患者的功能和结构分析。
Sci Rep. 2025 Mar 28;15(1):10810. doi: 10.1038/s41598-025-95328-9.
2
Functional and Structural Changes in Patients with Spinal Muscular Atrophy Treated in Poland during 12-Month Follow-Up: A Prospective Cohort Study.波兰脊髓性肌萎缩症患者在12个月随访期间的功能和结构变化:一项前瞻性队列研究
J Clin Med. 2024 Jul 19;13(14):4232. doi: 10.3390/jcm13144232.
3
Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy.

本文引用的文献

1
Neck and Trunk Muscle Strength in Children With Spinal Muscular Atrophy Is Lower Than in Healthy Controls and Depends on Disease Type.脊髓性肌萎缩症患儿的颈部和躯干肌肉力量低于健康对照儿童,且取决于疾病类型。
Front Neurol. 2021 Apr 30;12:628414. doi: 10.3389/fneur.2021.628414. eCollection 2021.
2
Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.依库珠单抗治疗脊髓性肌萎缩症 1 型 - 波兰扩展准入计划的结果。
Neurol Neurochir Pol. 2021;55(3):289-294. doi: 10.5603/PJNNS.a2021.0020. Epub 2021 Feb 10.
3
The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy.
脊髓性肌萎缩症患者上肢功能检查及其与粗大运动功能和结构参数的关系
Biomedicines. 2023 Mar 24;11(4):1005. doi: 10.3390/biomedicines11041005.
4
Prospective Analysis of Functional and Structural Changes in Patients with Spinal Muscular Atrophy-A Pilot Study.脊髓性肌萎缩症患者功能和结构变化的前瞻性分析——一项初步研究
Biomedicines. 2022 Dec 8;10(12):3187. doi: 10.3390/biomedicines10123187.
首款用于治疗脊髓性肌萎缩症的口服小分子药物。
Neurosci Insights. 2020 Nov 23;15:2633105520973985. doi: 10.1177/2633105520973985. eCollection 2020.
4
Cervical rotation, chest deformity and pelvic obliquity in patients with spinal muscular atrophy.脊髓性肌萎缩症患者的颈椎旋转、胸廓畸形和骨盆倾斜
BMC Musculoskelet Disord. 2020 Nov 7;21(1):726. doi: 10.1186/s12891-020-03710-7.
5
Risdiplam: First Approval.利司扑兰:首个获批药物
Drugs. 2020 Nov;80(17):1853-1858. doi: 10.1007/s40265-020-01410-z.
6
Regional and experiential differences in surgeon preference for the treatment of cervical facet injuries: a case study survey with the AO Spine Cervical Classification Validation Group.术者对颈椎小关节损伤治疗偏好的区域性和经验性差异:一项应用 AO 脊柱颈椎分类验证组的病例研究调查。
Eur Spine J. 2021 Feb;30(2):517-523. doi: 10.1007/s00586-020-06535-z. Epub 2020 Jul 22.
7
Drug treatment for spinal muscular atrophy types II and III.脊髓性肌萎缩症II型和III型的药物治疗。
Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5.
8
Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies.依库珠单抗治疗晚发性脊髓性肌萎缩症:1/2 期研究的长期结果。
Neurology. 2019 May 21;92(21):e2492-e2506. doi: 10.1212/WNL.0000000000007527. Epub 2019 Apr 24.
9
Reliability of four tests to assess body posture and the range of selected movements in individuals with spinal muscular atrophy.四种测试评估脊髓性肌萎缩症患者身体姿势及特定运动范围的可靠性。
BMC Musculoskelet Disord. 2019 Feb 7;20(1):54. doi: 10.1186/s12891-018-2389-8.
10
Nusinersen: A Treatment for Spinal Muscular Atrophy.依库珠单抗:治疗脊髓性肌萎缩症的一种方法。
Ann Pharmacother. 2019 Jan;53(1):61-69. doi: 10.1177/1060028018789956. Epub 2018 Jul 16.